Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$820.35M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Moderna, Inc.(MRNA)2,308,1902,308,1900$161.64M$444.49M54.18%+$282.85M
Personalis, Inc.(PSNL)14,044,94314,044,9430$188.20M$228.65M27.87%+$40.45M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$88.54M$86.32M10.52%-$2.22M
Aktis Oncology, Inc.(AKTS)952,844952,8440$30.71M$18.55M2.26%-$12.16M
Eikon Therapeutics Inc1,666,6661,666,6660$21.75M$13.40M1.63%-$8.35M
Entrada Therapeutics Inc1,739,7681,739,7680$12.80M$11.05M1.35%-$1.76M
Alector Inc3,545,7193,545,7190$7.13M$6.56M0.80%-$567.3K
Sutro Biopharma Inc272,351272,3510$9.04M$4.39M0.53%-$4.65M
Evaxion AsADS1,214,1261,214,1260$3.76M$3.98M0.49%+$218.5K
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$1.72M$1.92M0.23%+$207.4K
Xilio Therapeutics Inc105,982105,9820$1.02M$959.1K0.12%-$56.2K
Tuhura Biosciences Inc19,44519,4450$45.5K$40.8K0.00%-$4.7K
Neuphoria Therapeutics Inc10,02710,0270$43.8K$35.7K0.00%-$8.1K
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q3 2026 | TickerTrail